Novo Nordisk stock crashed Friday after the firm's next-generation weight-loss drug missed expectations in a highly ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

Y Intercept Hong Kong Ltd bought a new position in Allient Inc. (NASDAQ:ALNT – Free Report) in the third quarter, ...

BNP Paribas Financial Markets lifted its holdings in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 2,166.4% during the third quarter, according to the company in its most recent 13F filing ...

Novo Nordisk's controlling shareholder, Novo Holdings, has bought Catalent in a $16.5 billion deal that closed earlier Wednesday. At the time the deal was announced, Novo Nordisk (DK:NOVO.B), the ...

Novo Nordisk ( (NVO) ) has provided an announcement.

Novo Holdings A/S completed the acquisition of Catalent, Inc. (CTLT), a global contract development and manufacturing ...

Novo Holdings, the controlling shareholder of Novo Nordisk, on Wednesday sealed its $16.5 billion deal for Catalent, as the ...

Novo Holdings said that it completed it's $16.5 billion acquisition of Catalent Inc. (NYSE:CTLT). Shortly following the ...

Pain has really been out of favor in the industry up until very recently,” said John Mulcahy, SiteOne Therapeutics’ CEO. The ...

SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target ...